The influence of cancer-related distress and sense of coherence on anxiety and depression in patients with hereditary cancer: a study of patients' sense of coherence 6 months after genetic counseling.
This study examines the association between Sense of Coherence and anxiety and depression amongst patients at risk of hereditary cancer receiving genetic counseling. When writing this article, 144 patients referred for genetic counseling due to a suspicion of hereditary cancer in the family were recruited for this multicentered longitudinal study on the psychosocial aspects of genetic counseling in Norway. A total of 96 (66%) patients responded to the follow-up survey distributed 6 months after genetic counseling. This survey included the Sense of Coherence-29 Scale, Impact of Event Scale, and Hospital Anxiety and Depression Scale. Multiple regression analyses were applied. Our results show association between cancer-related distress and symptoms of anxiety and depression. Sense of Coherence is significantly associated with both anxiety and depression. The hypothesis of Sense of Coherence buffering cancer-related distress and the possible impact of these findings for genetic counseling are discussed.
Siglen
Elen
E
Section of Nursing Science, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway. elen.siglen@helse-bergen.no
Bjorvatn
Cathrine
C
Engebretsen
Lars Fredrik
LF
Berglund
Gunilla
G
Natvig
Gerd Karin
GK
D001007:Anxiety; D003863:Depression; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D006801:Humans; D008137:Longitudinal Studies; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000523:psychology*; D013315:Stress, Psychological
J Epidemiol Community Health. 2005 Jun;59(6):460-6
15911640
Radiother Oncol. 1993 Jun;27(3):193-7
7692472
Aust N Z J Psychiatry. 2002 Apr;36(2):246-50
11982548
Eur J Cancer Care (Engl). 2000 Sep;9(3):151-7
11881724
Psychooncology. 2001 Nov-Dec;10(6):459-68
11747058
Clin Rehabil. 2003 Jul;17(4):443-53
12785253
Health Qual Life Outcomes. 2003 Aug 01;1:29
12914662
J Epidemiol Community Health. 2006 May;60(5):376-81
16614325
Psychooncology. 2002 Nov-Dec;11(6):479-94
12476430
Psychol Rep. 1997 Jun;80(3 Pt 2):1211-20
9246887
Soc Sci Med. 1997 Jun;44(12):1771-9
9194239
Cancer. 1992 Jul 1;70(1):120-5
1606533
Soc Sci Med. 2001 Sep;53(5):603-14
11478540
J Psychosom Res. 2003 Nov;55(5):427-35
14581097
Psychosom Med. 1979 May;41(3):209-18
472086
West J Nurs Res. 1999 Apr;21(2):182-97
11512176
Soc Sci Med. 1993 Mar;36(6):725-33
8480217
J Psychosom Res. 2001 Feb;50(2):77-86
11274664
Br J Psychiatry. 2002 Mar;180:205-9
11872511
J Pain Symptom Manage. 1998 Nov;16(5):298-306
9846024
J Clin Psychol. 1990 Jul;46(4):415-20
2212043
J Psychosom Res. 1997 Jan;42(1):17-41
9055211
J Epidemiol Community Health. 2005 Jun;59(6):440-2
15911636
J Rheumatol. 1992 Dec;19(12):1912-8
1294739
Clin Otolaryngol Allied Sci. 2001 Feb;26(1):19-24
11298161
J Natl Cancer Inst. 1995 Feb 15;87(4):286-92
7707420
J Genet Couns. 2004 Oct;13(5):425-45
15604640
J Psychosom Res. 2002 Feb;52(2):69-77
11832252
Eur J Cancer. 2001 Feb;37(3):376-84
11239760
Ann Behav Med. 2000 Winter;22(1):53-9
10892528
Br J Cancer. 1999 Feb;79(3-4):525-9
10027324
Fam Cancer. 2003;2(1):27-33
14574164
Psychosom Med. 2003 Sep-Oct;65(5):870-6
14508034
Oncol Nurs Forum. 1999 Jun;26(5):909-15
10382190
Psychother Psychosom. 2000 Nov-Dec;69(6):296-302
11070441
J Rheumatol. 1998 May;25(5):869-75
9598882